Skip to content

Eli Lilly LLY Common Stock

Common Stock at other companies

Amgen logo
AmgenAMGN
2.8B0.0%
Mannkind logo
MannkindMNKD
$3.09M+1.6%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
545M0.0%
McKesson logo
McKessonMCK
800M0.0%
Exelixis logo
ExelixisEXEL
400M0.0%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
450M0.0%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.09T+56.4%
Enterprise value$1.12T+53.8%
P/E42.9×-7.3×
P/S15×+2.0×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's common stock?
Eli Lilly (LLY) reported common stock of $590M in Q1 2026.
How has Eli Lilly's common stock changed year-over-year?
Eli Lilly's common stock decreased by 0.4% year-over-year, from $592.6M to $590M.
What is the long-term trend for Eli Lilly's common stock?
Over 5 years (2020 to 2025), Eli Lilly's common stock has grown at a -0.3% compound annual growth rate (CAGR), from $598.2M to $590M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).